We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Genetic Cause of Warburg Micro Syndrome Identified

By LabMedica International staff writers
Posted on 25 Nov 2013
A gene responsible for Warburg Micro syndrome, a rare genetic disease characterized by eye, brain, and endocrine abnormalities, has been identified by mutation screening.

Patients with Warburg Micro syndrome are severely challenged physically and mentally, unable to learn how to walk or speak, and become blind and paralyzed from an early age. More...


A collaborative team of scientists led by those at the Medical College of Wisconsin (Milwaukee, WI, USA) and the University of Edinburgh (UK) studied a cohort consisting of 77 individuals with a spectrum of Warburg micro syndrome (WARBM) disorders including 59 typical WARBM cases, five with the milder Martsolf syndrome, and 13 atypical cases. Some complementary studies were conducted in a murine model.

Mutation screening of the complete coding region of TBC1 Domain Family, Member 20 (TBC1D20), and three members of the RAS Oncogene Family RAB1A, RAB1B, and RAB2A was performed by direct sequence analysis in both directions by using genomic DNA extracted from venous blood. Real-time polymerase chain reaction (qPCR) analysis of genomic DNA from one individual was carried out on a LightCycler 480 (Roche Applied Science; Indianapolis, IN, USA) with primers designed to amplify coding regions of TBC1D20 as well as the 5′ and 3′ genes RanBP-Type and C3HC4-Type Zinc Finger Containing 1(RBCK1).

Clinical evaluation of individuals carrying pathogenic TBC1D20 mutations was sufficient to conclude that they cause a disease phenotype indistinguishable to that caused by mutations in genes encoding for Rab3 GTPase-activating protein catalytic subunit, RAB3GAP1, RAB3GAP2, or RAB18. The four genes do not comprise the full causative picture for Warburg Micro syndrome; in about half of the cases, the causing mutation was in none of those genes, which means there are additional novel genes contributing to the disease.

Duska J. Sidjanin, PhD, an associate professor of cell biology, neurobiology and anatomy and senior author of the study said, “These findings have implications not only for families affected with Warburg Micro syndrome, but also provide novel information about the genes and molecular pathways essential for human development that is relevant for more common developmental disorders such as epilepsy and autism.” The study was published on November 14, 2013, in the American Journal of Human Genetics.

Related Links:

Medical College of Wisconsin
University of Edinburgh 
Roche Applied Science



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.